Infant monitoring specialist Owlet was informed by the New York Stock Exchange that it has regained compliance with the NYSE’s continued listing standards.
Last year, Owlet was notified by the NYSE that it was not in compliance with Section 802.01B of the NYSE listed company manual because its average global market capitalization over a consecutive 30-day trading day period was below $50 million...
Baby technology company Owlet announced it is expanding its reach within Europe by extending access to its baby monitor Dream Sock in Greece, Poland, the Czech Republic, Romania, Slovakia, Hungary and Bulgaria.
Dream Sock, which received FDA clearance last November and CE Mark certification in May, wraps around a baby's foot and gathers live health readings of infants 0-18 months who weigh 6-30...
Infant monitoring specialist Owlet's Dream Sock has received CE Mark certification by the European Union, meeting its required safety and health requirements and paving the way for the device to be sold in Germany, France and the U.K. later this year.
The Dream Sock, which wraps around a baby's foot, is a nonprescription medical pulse oximetry solution for infants aged 1 to 18 months weighing 6...
Baby tech company Owlet and telehealth staffing and services company Wheel announced they are partnering to allow Wheel's clinicians to prescribe caregivers Owlet's medical pulse oximetry wire-free sock for infants.
Owlet's BabySat, which received FDA clearance last year, uses pulse oximetry technology to monitor a baby's heart rate and oxygen saturation level, and alerts caregivers when a...
Baby tech company Owlet reported a drop in revenue to $13.1 million in the second quarter of 2023, compared to $18.3 million for the same period last year. It also reached a milestone, garnering FDA clearance in June for BabySat, its medical pulse oximetry wire-free sock for infants.
The company reported a net loss of $8.5 million in Q2 2023, compared to $11.7 million in Q2 2022, and an...
Owlet, a tech company focusing on smart baby monitoring, announced it would proceed with a 1-for-14 reverse stock split of its Class A common stock effective July 7.
The announcement comes just one week after the company reported it obtained FDA clearance for its prescription pulse oximetry sock for infants dubbed BabySat.
The stock will trade on a split-adjusted basis when the New York Stock...
Owlet, a tech company focusing on smart baby monitoring, received FDA clearance for its medical pulse oximetry wire-free sock for infants dubbed BabySat.
BabySat uses pulse oximetry technology to monitor a baby's heart rate and oxygen saturation level and alerts caregivers when a reading is outside of prescribed ranges. The company says the device is for use per a healthcare provider's...
Telehealth and medical transportation company DocGo saw its shares rise after reporting its first quarter financial results, showing total revenue of $113 million with a net loss of $3.9 million.
The company reported a 19% decline in mobile health revenue from $90.1 million in the first quarter of 2022 to $72.9 million in the first quarter of 2023 but a 44% increase in transportation services...
Baby tech company Owlet cut expenses in the second half of the year as it made new submissions to the FDA, pitching the moves as steps toward profitability.
The company reported $69.2 million in revenue in 2022 compared to $75.8 million in 2021. Operating expenses were $107.9 million last year, compared to $90.9 million in 2021.
But Owlet said the increase was largely due to the launch of its...
Digital chronic condition management company DarioHealth posted a net loss of $15.9 million in the first quarter, slightly higher than the $15 million net loss from Q1 last year. But the company beat its revenue expectations with $8.06 million, a 124% increase from last year.
Total operating expenses were $19.9 million, compared with $15.4 million in Q1 2021 and $22.2 million during the fourth...
